Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors
- PMID: 11191838
- DOI: 10.1007/s002100000334
Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors
Abstract
Adaptive phenomena such as desensitization of autoreceptors are considered an important factor in the achievement of therapeutic efficacy of antidepressant drugs after chronic treatment. We have studied whether a chronic treatment with desipramine had a greater effect than a single dose on the extracellular concentrations of noradrenaline in the dorsal hippocampus. Administration of 10 mg/kg i.p. desipramine once daily for 14 days significantly raised the basal extracellular noradrenaline in the dorsal hippocampus 24 h but not 48 h after the last drug injection. A challenge dose of desipramine increased extracellular noradrenaline in rats treated chronically with vehicle and desipramine. The effect was significantly higher in rats treated chronically with desipramine 48 h but not 24 h after the last injection. An intraperitoneal administration of the alpha2-adrenoceptor agonist clonidine at the dose of 10 microg/kg significantly reduced extracellular noradrenaline in the control group but not in animals chronically treated with desipramine whereas 30 microg/kg clonidine produced a similar decrease in both groups. Three concentrations of clonidine (0.05, 0.5 and 1 microM) infused into the hippocampus significantly reduced extracellular noradrenaline to a similar extent in rats chronically treated with saline or desipramine. Fourty-eight hours after the last injection of the chronic treatment, [3H]RX-821002 binding to alpha2-adrenoceptors in the rat locus coeruleus measured by autoradiography was not significantly modified. A slight (17%) but significant decrease of neuronal uptake of [3H]noradrenaline was found in synaptosome preparations from dorsal hippocampus of rats chronically treated with desipramine, but this was likely due to a decrease in affinity. The results suggest that a repeated treatment with desipramine (10 mg/kg i.p. once daily for 14 days) facilitates its effect on extracellular noradrenaline in the dorsal hippocampus and induces adaptive changes probably involving desensitization of alpha2-adrenoceptors, with no changes in their density, on noradrenergic neurons in the locus coeruleus.
Similar articles
-
Chronic reboxetine desensitizes terminal but not somatodendritic alpha2-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampus.Neuropsychopharmacology. 2005 Jun;30(6):1048-55. doi: 10.1038/sj.npp.1300661. Neuropsychopharmacology. 2005. PMID: 15668723
-
Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study.Br J Pharmacol. 2001 Aug;133(8):1362-70. doi: 10.1038/sj.bjp.0704196. Br J Pharmacol. 2001. PMID: 11498523 Free PMC article.
-
Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain.Br J Pharmacol. 1999 Nov;128(6):1332-8. doi: 10.1038/sj.bjp.0702926. Br J Pharmacol. 1999. PMID: 10578149 Free PMC article.
-
Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies.Prog Neuropsychopharmacol Biol Psychiatry. 2004 Aug;28(5):819-27. doi: 10.1016/j.pnpbp.2004.05.026. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 15363606 Review.
-
Presynaptic Adrenoceptors.Handb Exp Pharmacol. 2024;285:185-245. doi: 10.1007/164_2024_714. Handb Exp Pharmacol. 2024. PMID: 38755350 Review.
Cited by
-
Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex.Br J Pharmacol. 2001 Jan;132(1):183-8. doi: 10.1038/sj.bjp.0703821. Br J Pharmacol. 2001. PMID: 11156576 Free PMC article.
-
Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine.Neuropsychopharmacology. 2008 Dec;33(13):3190-200. doi: 10.1038/npp.2008.45. Epub 2008 Apr 16. Neuropsychopharmacology. 2008. PMID: 18418364 Free PMC article.
-
Effects of psychotropic agents on extinction of lever-press avoidance in a rat model of anxiety vulnerability.Front Behav Neurosci. 2014 Sep 15;8:322. doi: 10.3389/fnbeh.2014.00322. eCollection 2014. Front Behav Neurosci. 2014. PMID: 25309372 Free PMC article.
-
Differential modulation of α-1 adrenoceptor subtypes by antidepressants in the rat brain.J Neural Transm (Vienna). 2010 Dec;117(12):1423-30. doi: 10.1007/s00702-010-0522-4. Epub 2010 Dec 7. J Neural Transm (Vienna). 2010. PMID: 21136124
-
The antidepressant desipramine is an arrestin-biased ligand at the α(2A)-adrenergic receptor driving receptor down-regulation in vitro and in vivo.J Biol Chem. 2011 Oct 14;286(41):36063-36075. doi: 10.1074/jbc.M111.261578. Epub 2011 Aug 22. J Biol Chem. 2011. PMID: 21859713 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources